Lincoln National Corp’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,165
Closed -$24.9K 1228
2023
Q4
$24.9K Sell
3,165
-12,850
-80% -$101K ﹤0.01% 1094
2023
Q3
$70.8K Hold
16,015
﹤0.01% 1004
2023
Q2
$557K Buy
16,015
+6,300
+65% +$219K 0.01% 562
2023
Q1
$212K Hold
9,715
﹤0.01% 910
2022
Q4
$210K Buy
9,715
+2,050
+27% +$44.3K ﹤0.01% 857
2022
Q3
$187K Hold
7,665
﹤0.01% 820
2022
Q2
$156K Buy
7,665
+2,500
+48% +$50.9K ﹤0.01% 819
2022
Q1
$184K Hold
5,165
﹤0.01% 872
2021
Q4
$140K Sell
5,165
-7,500
-59% -$203K ﹤0.01% 862
2021
Q3
$550K Hold
12,665
0.01% 474
2021
Q2
$631K Buy
+12,665
New +$631K 0.01% 427